Company & Sponsor Intelligence
Ann & Robert H Lurie Children's Hospital of Chicago
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed1
Countries1
Therapeutic footprint
adhdneuromuscularother_neurology
Indexed studies
NCT01367964Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
other_neurology · United StatesNA
other_neurology · United StatesNA
NCT02036463A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy
neuromuscular · United StatesPHASE2
neuromuscular · United StatesPHASE2
NCT07203014Parent-Educator Action Response
adhd · United StatesNA
adhd · United StatesNA
NCT05796427Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD
adhd · United StatesNA
adhd · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →